Trial Profile
Bioavailability and pharmacokinetics of intranasal dexmedetomidine in children
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Oct 2020
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Pharmacokinetics
- Acronyms PINDEX
- 11 Sep 2018 Status changed from active, no longer recruiting to completed.
- 11 Sep 2017 Planned End Date changed from 1 Dec 2019 to 31 May 2018.
- 11 Sep 2017 Status changed from not yet recruiting to active, no longer recruiting.